Preclinical WebsiteClinical Website

Cuprizone Models

The cuprizone MS mouse model of demyelination & remyelination is induced by feeding mice the copper-chelating cuprizone toxin. Cuprizone administration in mice models several aspects of human multiple sclerosis (MS), including demyelination, spontaneous remyelination, oligodendrocyte precursor cell (OPC) proliferation & maturation, astrogliosis, and microgliosis.

The pathology in this demyelination model is primarily limited to the corpus callosum with a highly predictable timecourse. This demyelination mouse model is well-suited to therapeutic efficacy studies.

Two brain cross-sections stained for Myelin Basic Protein (MBP), used in studying demyelination in a cuprizone mouse model of Multiple Sclerosis (MS), with varying levels of myelin indicated by the staining intensity

EAE Models

Experimental Autoimmune Encephalomyelitis (EAE) is a gold-standard multiple sclerosis mouse model for assessing therapeutic agents targeting autoimmune-mediated CNS disease. The EAE induction is most commonly performed by immunizing mice against myelin-derived antigens, such as MOG, MBP, and PLP. EAE mice model several aspects of human MS.

This model of multiple sclerosis is a primarily T cell-mediated autoimmune disease with several key pathologic features, including demyelination, peripheral inflammation (lymphocytes, macrophages), microgliosis, astrogliosis, and axonal damage/injury & axon degeneration.

Histological section, which is often used in the study of Experimental Autoimmune Encephalomyelitis (EAE) models

Following MOG-EAE induction, mice demonstrate hindlimb paralysis and spinal cord pathology. Various fluid-based biomarkers (e.g. neurofilament light chain, inflammatory cytokines) can be found in the CSF collected from the cisterna magna of EAE mice.

Learn more about our characterization of these MS mouse models, our validated measures, and our Preclinical Neuroscience CRO services.

FAQs

What is Cuprizone?


What is MOG EAE?


Are motor symptoms observed in these multiple sclerosis mouse models?


Can Biospective identify different stages of oligodendrocyte maturation?


Related Content

Up-to-date information on Multiple Sclerosis and best practices related to the evaluation of therapeutic agents in MS animal models.

More Information

Let us know what you’re interested in. Our team will be happy to discuss with you!

Email us at i[email protected] or simply complete & submit the form below. 

Name*
Email*
Phone Number*
Affiliation (Company/University)*
Message*

Your privacy is important to us. We will protect your data as outlined in our Privacy Notice.

I agree to the terms in the Privacy Notice*

We use necessary cookies to make our site work. We also use other cookies to help us make improvements by measuring how you use the site or for marketing purposes. You have the choice to accept or reject them all. For more detailed information about the cookies we use, see our Privacy Notice.